Slayback Pharma LLC
39Patents
38Active
39Granted
62Portfolio score
Filing activity: Oct 25, 2018 → Aug 5, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10874671B2 | Pharmaceutical compositions of nilotinib | Human Necessities | 9 | Active |
| US11590122B2 | Pharmaceutical compositions of cabozantinib | Human Necessities | 4 | Active |
| US11707450B1 | Stable pharmaceutical compositions of bendamustine | Human Necessities | 4 | Active |
| US11679105B1 | Pharmaceutical compositions of cabozantinib | Human Necessities | 3 | Active |
| US11793809B2 | Pharmaceutical compositions of nilotinib | Human Necessities | 2 | Active |
| US11878025B2 | Pharmaceutical compositions of mifepristone | Human Necessities | 1 | Active |
| US12233049B2 | Stable pharmaceutical compositions of clonidine | Human Necessities | 0 | Active |
| US11844784B2 | Stable pharmaceutical compositions of bendamustine | Human Necessities | 0 | Active |
| US11110054B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US10952981B2 | Liquid pharmaceutical compositions of baclofen for oral administration | Human Necessities | 0 | Active |
| US12138255B2 | Pharmaceutical compositions of cabozantinib | Human Necessities | 0 | Active |
| US11931370B2 | Stable pharmaceutical compositions of cyclophosphamide | Human Necessities | 0 | Active |
| US11766438B2 | Pharmaceutical compositions of tofacitinib for oral administration | Human Necessities | 0 | Active |
| US11564898B1 | Stable oral suspensions of baclofen | Human Necessities | 0 | Active |
| US12059406B2 | Stable pharmaceutical compositions of bendamustine | General | 0 | Revoked |
| US11786512B2 | Stable pharmaceutical compositions of dihydroergotamine mesylate | Human Necessities | 0 | Active |
| US12097197B2 | Stable liquid compositions of netupitant and palonosetron | Human Necessities | 0 | Active |
| US11103503B2 | Pharmaceutical compositions of Lurasidone | Human Necessities | 0 | Active |
| US11484518B1 | Stable oral suspensions of baclofen | Human Necessities | 0 | Active |
| US12151020B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US11938217B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US10702520B1 | Pharmaceutical compositions of posaconazole | Human Necessities | 0 | Active |
| US12194028B2 | Stable pharmaceutical compositions of apixaban | Human Necessities | 0 | Active |
| US10456354B1 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US11040008B2 | Pharmaceutical compositions of meloxicam | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.